Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Gains from Investment Securities (2016 - 2025)

Aethlon Medical filings provide 15 years of Gains from Investment Securities readings, the most recent being -$15983.0 for Q1 2025.

  • On a quarterly basis, Gains from Investment Securities fell 150.73% to -$15983.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $24434.0, a 127.45% increase, with the full-year FY2025 number at $6546.0, up 350.21% from a year prior.
  • Gains from Investment Securities hit -$15983.0 in Q1 2025 for Aethlon Medical, down from $46730.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q4 2022 to a low of -$131148.0 in Q1 2023.
  • Median Gains from Investment Securities over the past 5 years was $28134.0 (2021), compared with a mean of $153222.3.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 12467.92% in 2022 and later crashed 1332.48% in 2023.
  • Aethlon Medical's Gains from Investment Securities stood at $13557.0 in 2021, then skyrocketed by 12467.92% to $1.7 million in 2022, then crashed by 90.78% to $157064.0 in 2023, then tumbled by 70.25% to $46730.0 in 2024, then crashed by 134.2% to -$15983.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$15983.0 (Q1 2025), $46730.0 (Q4 2024), and $3832.0 (Q3 2024) per Business Quant data.